Bain-Backed Zelis Said to Weigh Sale, IPO at $15 Billion Value

The private equity owners of Zelis are weighing options for the health-care technology company, including a possible sale, people with knowledge of the matter said.

Bain Capital and Parthenon Capital have been speaking with potential advisers about exploring a sale or initial public offering of US-based Zelis, according to the people. They’re also open to bringing in new investors to Zelis in a private transaction as well, they said.

Zelis could be valued at $15 billion or more in any deal, one of the people said, asking not to be identified discussing confidential information.

Deliberations are in the early stages ...